FDA Inspection 1312756 — Dr. Radomir Naumovic
The FDA completed an inspection of Dr. Radomir Naumovic on Apr 3, 2026 in Belgrade. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 3, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Belgrade (Serbia)
Additional details
Clinical Investigator (CI)